Annual SGA
$29.94 M
+$3.27 M+12.25%
September 30, 2024
Summary
- As of February 24, 2025, OTLK annual SGA is $29.94 million, with the most recent change of +$3.27 million (+12.25%) on September 30, 2024.
- During the last 3 years, OTLK annual SGA has risen by +$17.17 million (+134.48%).
- OTLK annual SGA is now at all-time high.
Performance
OTLK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$11.95 M
+$1.59 M+15.38%
December 31, 2024
Summary
- As of February 24, 2025, OTLK quarterly SGA is $11.95 million, with the most recent change of +$1.59 million (+15.38%) on December 31, 2024.
- Over the past year, OTLK quarterly SGA has stayed the same.
- OTLK quarterly SGA is now at all-time high.
Performance
OTLK Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.21 B
-$46.81 M-2.16%
December 31, 2024
Summary
- As of February 24, 2025, OTLK TTM SGA is -$2.21 billion, with the most recent change of -$46.81 million (-2.16%) on December 31, 2024.
- Over the past year, OTLK TTM SGA has dropped by -$2.25 billion (-6227.38%).
- OTLK TTM SGA is now -2251.11% below its all-time high of -$94.06 million.
Performance
OTLK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
OTLK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.3% | 0.0% | -6227.4% |
| 3 y3 years | +134.5% | +106.9% | -10000.0% |
| 5 y5 years | +219.5% | +510.4% | -10000.0% |
OTLK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.5% | at high | +264.5% | -64.2% | at low |
| 5 y | 5-year | at high | +219.5% | at high | +510.4% | -119.0% | at low |
| alltime | all time | at high | +309.1% | at high | +6407.7% | -2251.1% | at low |
Outlook Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $11.95 M(+15.4%) | $36.09 M(+20.6%) |
| Sep 2024 | $29.94 M(+12.2%) | $10.35 M(+23.8%) | $29.94 M(+10.5%) |
| Jun 2024 | - | $8.36 M(+53.9%) | $27.10 M(+5.1%) |
| Mar 2024 | - | $5.43 M(-6.3%) | $25.78 M(-3.2%) |
| Dec 2023 | - | $5.79 M(-22.9%) | $26.64 M(-0.1%) |
| Sep 2023 | $26.67 M(+28.6%) | $7.51 M(+6.7%) | $26.67 M(+10.4%) |
| Jun 2023 | - | $7.04 M(+11.9%) | $24.16 M(+5.5%) |
| Mar 2023 | - | $6.29 M(+8.0%) | $22.89 M(-1.7%) |
| Dec 2022 | - | $5.83 M(+16.6%) | $23.29 M(+12.3%) |
| Sep 2022 | $20.74 M(+62.4%) | $5.00 M(-13.5%) | $20.74 M(+7.8%) |
| Jun 2022 | - | $5.77 M(-13.7%) | $19.24 M(+17.4%) |
| Mar 2022 | - | $6.69 M(+104.1%) | $16.40 M(+18.8%) |
| Dec 2021 | - | $3.28 M(-6.4%) | $13.80 M(+8.1%) |
| Sep 2021 | $12.77 M(+28.1%) | $3.50 M(+19.5%) | $12.77 M(+9.5%) |
| Jun 2021 | - | $2.93 M(-28.5%) | $11.66 M(-3.0%) |
| Mar 2021 | - | $4.10 M(+82.7%) | $12.02 M(+21.7%) |
| Dec 2020 | - | $2.24 M(-6.2%) | $9.88 M(-0.9%) |
| Sep 2020 | $9.97 M(+6.4%) | $2.39 M(-27.3%) | $9.97 M(-3.8%) |
| Jun 2020 | - | $3.29 M(+67.9%) | $10.36 M(+16.3%) |
| Mar 2020 | - | $1.96 M(-16.2%) | $8.91 M(+1.2%) |
| Dec 2019 | - | $2.34 M(-16.0%) | $8.80 M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | $9.37 M(-34.1%) | $2.78 M(+51.7%) | $9.37 M(-25.8%) |
| Jun 2019 | - | $1.83 M(-0.8%) | $12.62 M(-2.8%) |
| Mar 2019 | - | $1.85 M(-36.3%) | $12.99 M(-4.4%) |
| Dec 2018 | - | $2.90 M(-51.9%) | $13.58 M(-4.5%) |
| Sep 2018 | $14.23 M(-10.4%) | $6.04 M(+174.9%) | $14.23 M(+21.6%) |
| Jun 2018 | - | $2.20 M(-10.2%) | $11.70 M(-9.9%) |
| Mar 2018 | - | $2.45 M(-31.1%) | $12.99 M(-10.8%) |
| Dec 2017 | - | $3.55 M(+1.2%) | $14.56 M(-8.3%) |
| Sep 2017 | $15.88 M(-26.3%) | $3.51 M(+0.7%) | $15.88 M(-16.2%) |
| Jun 2017 | - | $3.48 M(-13.5%) | $18.95 M(-27.0%) |
| Mar 2017 | - | $4.02 M(-17.4%) | $25.97 M(+19.4%) |
| Dec 2016 | - | $4.87 M(-25.9%) | $21.76 M(+0.9%) |
| Sep 2016 | $21.56 M(+67.1%) | $6.57 M(-37.4%) | $21.56 M(+9.7%) |
| Jun 2016 | - | $10.50 M(-5646.3%) | $19.66 M(+66.4%) |
| Mar 2016 | - | -$189.40 K(-104.1%) | $11.81 M(-27.7%) |
| Dec 2015 | - | $4.67 M(+0.2%) | $16.34 M(+26.6%) |
| Sep 2015 | $12.91 M(+76.3%) | $4.67 M(+75.5%) | $12.91 M(+56.6%) |
| Jun 2015 | - | $2.66 M(-38.7%) | $8.24 M(+47.7%) |
| Mar 2015 | - | $4.34 M(+250.8%) | $5.58 M(+350.8%) |
| Dec 2014 | - | $1.24 M | $1.24 M |
| Sep 2014 | $7.32 M | - | - |
FAQ
- What is Outlook Therapeutics annual SGA?
- What is the all time high annual SGA for Outlook Therapeutics?
- What is Outlook Therapeutics annual SGA year-on-year change?
- What is Outlook Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly SGA year-on-year change?
- What is Outlook Therapeutics TTM SGA?
- What is the all time high TTM SGA for Outlook Therapeutics?
- What is Outlook Therapeutics TTM SGA year-on-year change?
What is Outlook Therapeutics annual SGA?
The current annual SGA of OTLK is $29.94 M
What is the all time high annual SGA for Outlook Therapeutics?
Outlook Therapeutics all-time high annual SGA is $29.94 M
What is Outlook Therapeutics annual SGA year-on-year change?
Over the past year, OTLK annual SGA has changed by +$3.27 M (+12.25%)
What is Outlook Therapeutics quarterly SGA?
The current quarterly SGA of OTLK is $11.95 M
What is the all time high quarterly SGA for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly SGA is $11.95 M
What is Outlook Therapeutics quarterly SGA year-on-year change?
Over the past year, OTLK quarterly SGA has changed by $0.00 (0.00%)
What is Outlook Therapeutics TTM SGA?
The current TTM SGA of OTLK is -$2.21 B
What is the all time high TTM SGA for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM SGA is -$94.06 M
What is Outlook Therapeutics TTM SGA year-on-year change?
Over the past year, OTLK TTM SGA has changed by -$2.25 B (-6227.38%)